Search

Author/Creator Vergniol, J.

1. 2305 Randomized phase 2/3 trial of transcatheter arterial chemoembolization (TACE) plus sunitinib or placebo in patients with hepatocellular carcinoma (HCC) (PRODIGE 16/SATURNE study): Results of the Phase II part. (September 2015)

Authors:
Hebbar, M.; Heurgue-Berlot, A.; Boige, V.; Le Malicot, K.; Bernard-Chabert, B.; Marcus, C.; Dharancy, S.; Sergent, G.; Perarnau, J.M.; Ehrhard, F.; Ollivier-Hourmand, I.; Vergniol, J.; Michel, P.; Edeline, J.; Rinaldi, Y.; Seitz, J.F.; Lepage, C.; De Baere, T.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S434
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials. (July 2018)

Authors:
Adenis, A.; Alessio, A.; Aouakli, A.; Azzedine, A.; Bedjaoui, A.; Bidault, A.; Blanchi, A.; Botton, A.; Cadier-Lagnes, A.; Fatisse, A.; Gagnaire, A.; Gilbert, A.; Gueye, A.; Hollebecque, A.; Lemaire, A.; Mahamat, A.; Marre, A.; Patenotte, A.; Rotenberg, A.; Roussel, A.
Journal:
European journal of cancer
Issue:
Volume 98(2018)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Serial combination of noninvasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with nonalcoholic fatty liver disease. Issue 1 (16th February 2017)

Authors:
Petta, S.; Wong, V.W.-S.; Cammà, C.; Hiriart, J.-B.; Wong, G.L.-H.; Vergniol, J.; Chan, A.W.-H.; Di Marco, V.; Merrouche, W.; Chan, H.L.-Y.; Marra, F.; Le-Bail, B.; Arena, U.; Craxì, A.; de Ledinghen, V.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e2
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Serial combination of non‐invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD. Issue 6 (27th July 2017)

Authors:
Petta, S.; Wong, V. W.‐S.; Cammà, C.; Hiriart, J.‐B.; Wong, G. L.‐H.; Vergniol, J.; Chan, A. W.‐H.; Di Marco, V.; Merrouche, W.; Chan, H. L.‐Y.; Marra, F.; Le‐Bail, B.; Arena, U.; Craxì, A.; de Ledinghen, V.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 46:Issue 6(2017)
Page Start:
617
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. The CUPIC algorithm: an accurate model for the prediction of sustained viral response under telaprevir or boceprevir triple therapy in cirrhotic patients. Issue 12 (27th July 2015)

Authors:
Boursier, J.; Ducancelle, A.; Vergniol, J.; Veillon, P.; Moal, V.; Dufour, C.; Bronowicki, J.‐P.; Larrey, D.; Hézode, C.; Zoulim, F.; Fontaine, H.; Canva, V.; Poynard, T.; Allam, S.; De Lédinghen, V.; the ANRS CO20 CUPIC Study Group
Journal:
Journal of viral hepatitis
Issue:
Volume 22:Issue 12(2015)
Page Start:
1002
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗